phase readout
saveNCT04844866: Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
RECRUITINGupdated 57m ago
community read0 votes
Sponsor: Miltenyi Biomedicine GmbH. Phase: PHASE2. Conditions: Diffuse Large B-cell Lymphoma
view source ↗
comments(0)
5-min edit window · permanent after that